HDC HOLDINGSLtd Resultados de beneficios anteriores
Pasado controles de criterios 4/6
HDC HOLDINGSLtd's earnings have been declining at an average annual rate of -27.3%, while the Chemicals industry saw earnings growing at 7.7% annually. Revenues have been growing at an average rate of 22.1% per year. HDC HOLDINGSLtd's return on equity is 4.6%, and it has net margins of 2.2%.
Información clave
-27.3%
Tasa de crecimiento de los beneficios
-24.1%
Tasa de crecimiento del BPA
Crecimiento de la industria Chemicals | 13.9% |
Tasa de crecimiento de los ingresos | 22.1% |
Rentabilidad financiera | 4.6% |
Margen neto | 2.2% |
Última actualización de beneficios | 30 Jun 2024 |
Actualizaciones de resultados anteriores recientes
Recent updates
HDC HOLDINGS CO.,Ltd's (KRX:012630) Shares Bounce 25% But Its Business Still Trails The Market
Aug 09HDC HOLDINGSLtd's (KRX:012630) Soft Earnings Are Actually Better Than They Appear
Mar 24Does HDC HOLDINGSLtd (KRX:012630) Have A Healthy Balance Sheet?
Mar 04Would HDC HOLDINGS CO.,Ltd (KRX:012630) Be Valuable To Income Investors?
Feb 11What Are The Total Returns Earned By Shareholders Of HDC HOLDINGSLtd (KRX:012630) On Their Investment?
Jan 17What You Need To Know About HDC HOLDINGS CO.,Ltd's (KRX:012630) Investor Composition
Dec 25HDC HOLDINGSLtd (KRX:012630) Has A Somewhat Strained Balance Sheet
Dec 04Desglose de ingresos y gastos
Cómo gana y gasta dinero HDC HOLDINGSLtd. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).
Historial de beneficios e ingresos
Fecha | Ingresos | Beneficios | Gastos G+A | Gastos de I+D |
---|---|---|---|---|
30 Jun 24 | 5,960,225 | 128,764 | 302,007 | 0 |
31 Mar 24 | 5,789,238 | 114,682 | 300,066 | 0 |
31 Dec 23 | 5,908,285 | 113,060 | 301,046 | 0 |
30 Sep 23 | 5,648,970 | 81,268 | 307,675 | 0 |
30 Jun 23 | 5,355,744 | 54,951 | 304,415 | 0 |
31 Mar 23 | 5,332,597 | 66,820 | 305,298 | 0 |
31 Dec 22 | 5,044,945 | -5,111 | 319,954 | 0 |
30 Sep 22 | 5,080,938 | -24,962 | 340,673 | 0 |
30 Jun 22 | 5,128,660 | 14,897 | 351,257 | 0 |
31 Mar 22 | 4,958,305 | 21,483 | 360,956 | 0 |
31 Dec 21 | 4,779,586 | 113,407 | 349,312 | 0 |
30 Sep 21 | 4,668,944 | 177,605 | 327,859 | 0 |
30 Jun 21 | 4,558,792 | 89,678 | 520,104 | 0 |
31 Mar 21 | 4,618,278 | 112,110 | 503,774 | 0 |
31 Dec 20 | 3,951,863 | 103,602 | 464,988 | 0 |
30 Sep 20 | 3,106,479 | 105,597 | 423,795 | 0 |
30 Jun 20 | 2,387,857 | 218,950 | 177,716 | 0 |
31 Mar 20 | 1,574,628 | 234,855 | 142,230 | 0 |
31 Dec 19 | 1,616,692 | 256,577 | 143,389 | 0 |
30 Sep 19 | 1,610,043 | 247,611 | 146,536 | 0 |
30 Jun 19 | 1,618,387 | 168,709 | 153,618 | 0 |
31 Mar 19 | 1,601,152 | 113,605 | 158,791 | 0 |
31 Dec 18 | 1,547,841 | 77,090 | 155,713 | 0 |
30 Sep 18 | 1,505,348 | 35,550 | 147,387 | 0 |
30 Jun 18 | 1,517,664 | 46,199 | 150,354 | 0 |
31 Mar 18 | 1,531,671 | 34,363 | 146,564 | 0 |
31 Dec 17 | 1,521,023 | 20,525 | 145,401 | 0 |
30 Sep 17 | 2,557,184 | 93,172 | 231,673 | 0 |
30 Jun 17 | 3,315,472 | 165,610 | 264,377 | 0 |
31 Mar 17 | 4,104,944 | 270,449 | 316,452 | 0 |
31 Dec 16 | 4,749,886 | 306,732 | 351,279 | 0 |
30 Sep 16 | 4,571,696 | 301,568 | 370,157 | 0 |
30 Jun 16 | 4,552,382 | 292,514 | 367,468 | 0 |
31 Mar 16 | 4,584,423 | 230,246 | 379,591 | 0 |
31 Dec 15 | 4,602,609 | 216,795 | 379,817 | 0 |
30 Sep 15 | 4,632,263 | 171,028 | 303,061 | 0 |
30 Jun 15 | 4,615,058 | 120,309 | 306,566 | 0 |
31 Mar 15 | 4,511,685 | 93,386 | 256,933 | 0 |
31 Dec 14 | 4,477,377 | 68,839 | 253,573 | 0 |
30 Sep 14 | 4,563,537 | -117,492 | 351,106 | 0 |
30 Jun 14 | 4,521,071 | -177,490 | 357,736 | 0 |
31 Mar 14 | 4,395,655 | -209,054 | 378,916 | 0 |
31 Dec 13 | 4,216,934 | -208,656 | 379,616 | 0 |
Ingresos de calidad: A012630 has high quality earnings.
Margen de beneficios creciente: A012630's current net profit margins (2.2%) are higher than last year (1%).
Análisis del flujo de caja libre vs. Beneficios
Análisis del crecimiento de los beneficios en el pasado
Tendencia de beneficios: A012630's earnings have declined by 27.3% per year over the past 5 years.
Acelerando crecimiento: A012630's earnings growth over the past year (134.3%) exceeds its 5-year average (-27.3% per year).
Beneficios vs. Industria: A012630 earnings growth over the past year (134.3%) exceeded the Chemicals industry -4.5%.
Rentabilidad financiera
Alta ROE: A012630's Return on Equity (4.6%) is considered low.